ICON’s Marie McCarthy, Pavel Lebesle, and Matthew McCarty discuss how to accelerate orphan drug development for patients with rare diseases in this Autumn 2018 Pharmafile article.

Cell and gene therapies insights

ICON's Cell and Gene Therapies team contributes regularly to industry publications and media coverage of cell and gene therapy clinical trials. Stay up to date with the latest trends in this therapeutic area through ICON's insights.

Read more cell and gene therapies insights